atorvastatin (1.2%)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for atorvastatin (1.2%), covering 2014-04-21 to 2014-04-21. Get the full timeline:
Most recent: Clinical Trial Update: PLATELET RICH FIBRIN COMBINED WITH 1.2% ATORVASTATIN FOR TREATMENT OF INTRABONY DEFECTS IN CHRONIC PERIODONTITIS [Phase 2]